3-Cyclopropylmethoxy-N-(3,5-dichloropyridin-4-yl)-4-(difluoromethoxy)benzamide

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

26 API Suppliers, 13 USDMF, 6 EU WC, 4 KDMF, 10 NDC API, 17 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

84 Drugs in Development

84 Drugs in Development

INTERMEDIATES

6 Intermediates Suppliers

6 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

47 FDF Dossiers, 23 FDA Orange Book, 14 Europe, 2 Canada, 1 South Africa, 7 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 250MCG, TABLET;ORAL - 500MCG

RELATED EXCIPIENT COMPANIES

3 SPI Pharma, 4 Faran Shimi Pharmaceutical, 1 Boai NKY Pharmaceuticals Ltd, 9 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 9 BASF, 2 DFE Pharma, 1 Gangwal Chemicals, 2 Ingredion Pharma Solutions, 15 Kerry, 8 Microlex e.U, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 4 Pluviaendo, 1 Prachin Chemical, 6 Roquette, 1 Seppic, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Sigachi Industries, 1 Ulanqab Kema New Material, 1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

47 Fillers, Diluents & Binders, 20 Direct Compression, 10 Granulation, 10 Co-Processed Excipients, 8 Lubricants & Glidants, 7 Solubilizers, 6 Disintegrants & Superdisintegrants, 5 Controlled & Modified Release, 4 Thickeners and Stabilizers, 3 Chewable & Orodispersible Aids, 3 Taste Masking, 3 Parenteral, 2 Coating Systems & Additives, 1 Emulsifying Agents, 1 Film Formers & Plasticizers